BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22012832)

  • 1. Contrast-enhanced ultrasound of hepatocellular carcinoma: Correlation of washout time and angiogenesis.
    Xia Y; Jiang YX; Dai Q; Xiao Y; Lv K; Wang L
    Clin Hemorheol Microcirc; 2011; 48(4):265-73. PubMed ID: 22012832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
    Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
    Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization.
    Pei XQ; Liu LZ; Zheng W; Cai MY; Han F; He JH; Li AH; Chen MS
    Eur J Radiol; 2012 Mar; 81(3):e182-8. PubMed ID: 21349669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
    Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
    Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma.
    Wang Z; Tang J; An L; Wang W; Luo Y; Li J; Xu J
    J Ultrasound Med; 2007 Jun; 26(6):757-62. PubMed ID: 17526607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: correlation with microvessel morphology.
    Xiao JD; Zhu WH; Shen SR
    Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):605-10. PubMed ID: 21134829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F
    J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative characterization of hepatocellular carcinoma (HCC)--perfusion with contrast-enhanced ultrasound and perfusion analysis.
    Schacherer D; Girlich C; Wiest R; Büttner R; Schölmerich J; Feuerbach S; Zorger N; Hamer OW; Jung EM
    Clin Hemorheol Microcirc; 2010; 44(2):97-105. PubMed ID: 20203364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
    Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
    Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of hepatocellular carcinoma by contrast-enhanced sonography: correlation with pathologic differentiation.
    Xu JF; Liu HY; Shi Y; Wei ZH; Wu Y
    J Ultrasound Med; 2011 May; 30(5):625-33. PubMed ID: 21527610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of portal vein tumor thrombosis in quantitative perfusion analysis of contrast-enhanced ultrasound of hepatocellular carcinoma.
    Wang Z; Liu G; Lu MD; Xie X; Kuang M; Wang W; Xu Z; Lin M; Chen L
    Ultrasound Med Biol; 2015 May; 41(5):1277-86. PubMed ID: 25623820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the microcirculation of hepatocellular carcinomas using contrast-enhanced ultrasound with intraarterial and intravenous contrast application during transarterial chemoembolization with drug-eluting beads (DEB-TACE): preliminary data.
    Uller W; Wiggermann P; Gössmann H; Klebl F; Salzberger B; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):55-66. PubMed ID: 22214678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion Characteristics of Hepatocellular Carcinoma at Contrast-enhanced Ultrasound: Influence of the Cellular differentiation, the Tumor Size and the Underlying Hepatic Condition.
    Yang D; Li R; Zhang XH; Tang CL; Ma KS; Guo DY; Yan XC
    Sci Rep; 2018 Mar; 8(1):4713. PubMed ID: 29549368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Early Recurrence of Hepatocellular Carcinoma after Surgical Resection.
    Wang Y; Liao J; Qi W; Xie L; Li Y
    Ultrasound Med Biol; 2016 May; 42(5):1042-8. PubMed ID: 26803390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.